These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38041505)

  • 1. Predictive value of protein-bound uremic toxins for heart failure in patients with chronic kidney disease.
    Zwaenepoel B; De Backer T; Glorieux G; Verbeke F
    ESC Heart Fail; 2024 Feb; 11(1):466-474. PubMed ID: 38041505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease.
    Glorieux G; Vanholder R; Van Biesen W; Pletinck A; Schepers E; Neirynck N; Speeckaert M; De Bacquer D; Verbeke F
    Nephrol Dial Transplant; 2021 May; 36(6):998-1005. PubMed ID: 33508125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.
    Chinnappa S; Tu YK; Yeh YC; Glorieux G; Vanholder R; Mooney A
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30563136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.
    Snauwaert E; Holvoet E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Godefroid N; Krid S; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Van Dyck M; Van Hoeck K; Collard L; Eloot S; Shroff R
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 31022857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain.
    El Amouri A; Snauwaert E; Foulon A; Vande Moortel C; Van Dyck M; Van Hoeck K; Godefroid N; Glorieux G; Van Biesen W; Vande Walle J; Raes A; Eloot S
    Pediatr Nephrol; 2021 Jun; 36(6):1589-1595. PubMed ID: 33387017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.
    Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R
    Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.
    Snauwaert E; Van Biesen W; Raes A; Glorieux G; Van Bogaert V; Van Hoeck K; Coppens M; Roels S; Vande Walle J; Eloot S
    Nephrol Dial Transplant; 2018 Jun; 33(6):978-986. PubMed ID: 28992139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury.
    André C; Bennis Y; Titeca-Beauport D; Caillard P; Cluet Y; Kamel S; Choukroun G; Maizel J; Liabeuf S; Bodeau S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122234. PubMed ID: 32615535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease.
    Verbeke F; Vanholder R; Van Biesen W; Glorieux G
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 36013188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
    Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers.
    Fabresse N; Larabi IA; Abe E; Lamy E; Rigothier C; Massy ZA; Alvarez JC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?
    Liabeuf S; Glorieux G; Lenglet A; Diouf M; Schepers E; Desjardins L; Choukroun G; Vanholder R; Massy ZA;
    PLoS One; 2013; 8(6):e67168. PubMed ID: 23826225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro.
    Yamamoto S; Ito T; Sato M; Goto S; Kazama JJ; Gejyo F; Narita I
    Blood Purif; 2019; 48(3):215-222. PubMed ID: 31055586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.